The Food and Drug Administration (FDA) has accepted two new drug applications Merck submitted for an investigational treatment aimed at ameliorating HIV-1 infection in adults, according to a company press release.
A recent study by University of California, Los Angeles (UCLA), researchers has provided important information on how the herpes virus, associated with a type of cancer, spreads and could aid in the development of antiviral drugs.
Research from the University of Colorado's Anschutz Medical Campus has shown that an antioxidant found in certain foods can stop the progression of fatty liver disease, which has become a major public health issue in the United States.
A new study by researchers at the University of Florida (UF) College of Public Health and Health Professions shows those who had significant weight loss start regaining their weight much sooner than originally believed.
Early retirees and certain self-employed individuals buying insurance on Affordable Care Act exchanges, particularly those managed federally, are hurting the most as they face increased premiums without benefiting from subsidies, including tax credits.
Hospital costs suffer from a deep lack of transparency, but a new "eye opening" report that reveals one common procedure costs nearly eight times more in one Minnesota facility than at another will help to inform policy debate, according to Minnesota's health economist.
Insomnia is pervasive and problematic nationwide, affecting the quality of life for a large number of adults, and electronic devices may be part of the reason, according to a Wake Forest Baptist Medical Center sleep specialist.
While multibillion-dollar mega-mergers at the top of the end of the health-sector chain garner headlines and potential regulatory scrutiny, hospital group consolidations are also concerning experts who believe they may not produce better care and lower costs.
A group advocating on behalf of those suffering from Alzheimer's has a word for Microsoft founder Bill Gates, who recently announced he's investing $100 million in disease research: Welcome to the fight.